Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided intra-articular bupivacaine, tenoxicam, and methylprednisolone for chronic knee osteoarthritis pain
PACTR202602873595988Phase 3Completed
- Sponsor
- Amany Saleh Abo Saleh Nasr
- Start
- Oct 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of bupivacaine, tenoxicam and methylprednisolone in knee osteoarthritis (OA) (3 arms), sponsored by Amany Saleh Abo Saleh Nasr. Started Oct 2017; status: completed.
02
Drugs
bupivacainetenoxicammethylprednisolone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on PACTR202602873595988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602873595988.